Takashi Hishida
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment 10
- Molecular Biology top 10%
- DNA Repair Mechanisms 27
- DNA and Nucleic Acid Chemistry 7
- CRISPR and Genetic Engineering 4
- RNA and protein synthesis mechanisms 4
- Cancer therapeutics and mechanisms 3
- Genetics top 10%
- Bacterial Genetics and Biotechnology 10
-
- Plant Genetic and Mutation Studies 6
- Co-authors
- Hiroshi IwasakiHideo ShinagawaYoshino KubotaTatsuya ShibataTakashi MorishitaKenji KeyamuraAntony M. CarrYoshizumi Ishino
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (3 papers)Nucleic Acids Research (2 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Takashi Hishida
30 papers receiving 847 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 182
- Molecular Biology 807
- Genetics 260
- Cell Biology 106
- Aging 8
Countries citing papers authored by Takashi Hishida
This map shows the geographic impact of Takashi Hishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Hishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Hishida more than expected).
Fields of papers citing papers by Takashi Hishida
This network shows the impact of papers produced by Takashi Hishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Hishida. The network helps show where Takashi Hishida may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Takashi Hishida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 6 | |
| 2 | 2023 | 0 | |
| 3 | 2021 | 3 | |
| 4 | 2020 | 7 | |
| 5 | 2020 | 1 | |
| 6 | 2019 | 15 | |
| 7 | 2016 | 14 | |
| 8 | 2013 | 35 | |
| 9 | 2012 | 11 | |
| 10 | 2012 | 51 | |
| 11 | 2009 | 13 | |
| 12 | 2008 | 67 | |
| 13 | 2008 | 16 | |
| 14 | 2006 | 53 | |
| 15 | 2005 | 15 | |
| 16 | 2005 | 37 | |
| 17 | 2004 | 105 | |
| 18 | 2003 | 7 | |
| 19 | 1999 | 53 | |
| 20 | 1998 | 17 |
About Takashi Hishida
Takashi Hishida is a scholar working on Cancer Research, Aging and Molecular Biology, having authored 31 papers that have together received 861 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (27 papers), Carcinogens and Genotoxicity Assessment (10 papers), Bacterial Genetics and Biotechnology (10 papers), DNA and Nucleic Acid Chemistry (7 papers), Plant Genetic and Mutation Studies (6 papers), CRISPR and Genetic Engineering (4 papers), RNA and protein synthesis mechanisms (4 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Cancer Research (182 citations), Molecular Biology (807 citations) and Genetics (260 citations). Takashi Hishida has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hiroshi Iwasaki, Hideo Shinagawa, Yoshino Kubota, Tatsuya Shibata, Takashi Morishita, Kenji Keyamura, Hideo Shinagawa, Antony M. Carr, Yoshizumi Ishino and Yong-Woon Han. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.